Acurx Pharmaceuticals, Inc. (ACXP): Price and Financial Metrics
ACXP Price/Volume Stats
Current price | $0.74 | 52-week high | $3.35 |
Prev. close | $0.76 | 52-week low | $0.68 |
Day low | $0.71 | Volume | 149,000 |
Day high | $0.76 | Avg. volume | 344,200 |
50-day MA | $0.81 | Dividend yield | N/A |
200-day MA | $1.76 | Market Cap | 12.64M |
ACXP Stock Price Chart Interactive Chart >
Acurx Pharmaceuticals, Inc. (ACXP) Company Bio
Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.
ACXP Price Returns
1-mo | -16.19% |
3-mo | -55.69% |
6-mo | -68.24% |
1-year | -77.05% |
3-year | -81.95% |
5-year | N/A |
YTD | -9.09% |
2024 | -78.75% |
2023 | -3.77% |
2022 | -7.90% |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...